A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study

Jitao Wang,1,2,* Zhanguo Zhang,3,* Dong Shang,4,* Yong Liao,2,* Peng Yu,5,* Jinling Li,2 Shubo Chen,2 Dengxiang Liu,2 Hongrui Miao,3 Shuang Li,4 Biao Zhang,4 Anliang Huang,4 Hao Liu,6 Yewei Zhang,7 Xiaolong Qi1 1Center of Portal Hypertension, Department of Rad...

Full description

Bibliographic Details
Main Authors: Wang J, Zhang Z, Shang D, Liao Y, Yu P, Li J, Chen S, Liu D, Miao H, Li S, Zhang B, Huang A, Liu H, Zhang Y, Qi X
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Online Access:https://www.dovepress.com/a-novel-nomogram-for-prediction-of-post-hepatectomy-liver-failure-in-p-peer-reviewed-fulltext-article-JHC
_version_ 1798037373383081984
author Wang J
Zhang Z
Shang D
Liao Y
Yu P
Li J
Chen S
Liu D
Miao H
Li S
Zhang B
Huang A
Liu H
Zhang Y
Qi X
author_facet Wang J
Zhang Z
Shang D
Liao Y
Yu P
Li J
Chen S
Liu D
Miao H
Li S
Zhang B
Huang A
Liu H
Zhang Y
Qi X
author_sort Wang J
collection DOAJ
description Jitao Wang,1,2,* Zhanguo Zhang,3,* Dong Shang,4,* Yong Liao,2,* Peng Yu,5,* Jinling Li,2 Shubo Chen,2 Dengxiang Liu,2 Hongrui Miao,3 Shuang Li,4 Biao Zhang,4 Anliang Huang,4 Hao Liu,6 Yewei Zhang,7 Xiaolong Qi1 1Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China; 2Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital of Hebei Medical University, Xingtai, People’s Republic of China; 3Hepatic Surgery Center, Tongji Hospital, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 4Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China; 5Department of Hepatobiliary Surgery, Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of China; 6Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 7Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaolong Qi, Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China, Email qixiaolong@vip.163.com Jitao Wang, Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital of Hebei Medical University, Xingtai, Hebei, People’s Republic of China, Email wangjt302@163.comObjective: To develop a nomogram for predicting post-hepatectomy liver failure (PHLF) in patients with resectable hepatocellular carcinoma (HCC) based on portal hypertension, the extent of resection, ALT, total bilirubin, and platelet count.Methods: Patients with HCC hospitalized from January 2015 to December 2020 were included in a retrospective cohort study. 595 HCC patients were divided into a training cohort (n=416) and a validation cohort (n=179) by random sampling. Univariate and multivariable analyses were performed to identify the independent variables to predict PHLF. The nomogram models for predicting the overall risk of PHLF and the risk of PHLF B+C were constructed based on the independent variables. Comparisons were made by using receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) with traditional models, such as FIB-4 score, APRI score, CP class (Child-Pugh), MELD score (model of end-stage liver disease), and ALBI score (albumin-bilirubin) to analyze the accuracy and superiority of the nomogram.Results: We discovered that portal hypertension (yes vs no) (OR=1.677,95% CI:1.817– 4.083, p=0.002), the extent of liver resection (OR=1.872,95% CI:3.937– 47.096, p=0.001), ALT (OR=1.003,95% CI:1.003– 1.016, P=0.003), total bilirubin (OR=1.036,95% CI:1.031– 1.184, p=0.005), and platelet count (OR= 1.004, 95% CI:0.982– 0.998, p=0.020) were independent risk factors for PHLF using multifactorial analysis. The nomogram models were constructed using well-fit calibration curves for each of these five covariates. When compared to the FIB4, ALBI, MELD, and CP score, our nomogram models have a better predictive value for predicting the overall risk of PHLF or the risk of PHLF B+C. The validation cohort’s results were consistent. DCA also confirmed the conclusion.Conclusion: Our models, in the form of static nomogram or web application, were developed to predict PHLF overall risk and PHLF B+C risk in patients with HCC, with a high prediction sensitivity and specificity performance than other commonly used scoring systems.Keywords: post-hepatectomy liver failure, hepatocellular carcinoma, nomogram, predictive model
first_indexed 2024-04-11T21:25:42Z
format Article
id doaj.art-4a8f0a13599f4e198719b7181f116681
institution Directory Open Access Journal
issn 2253-5969
language English
last_indexed 2024-04-11T21:25:42Z
publishDate 2022-08-01
publisher Dove Medical Press
record_format Article
series Journal of Hepatocellular Carcinoma
spelling doaj.art-4a8f0a13599f4e198719b7181f1166812022-12-22T04:02:24ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692022-08-01Volume 990191277725A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter StudyWang JZhang ZShang DLiao YYu PLi JChen SLiu DMiao HLi SZhang BHuang ALiu HZhang YQi XJitao Wang,1,2,* Zhanguo Zhang,3,* Dong Shang,4,* Yong Liao,2,* Peng Yu,5,* Jinling Li,2 Shubo Chen,2 Dengxiang Liu,2 Hongrui Miao,3 Shuang Li,4 Biao Zhang,4 Anliang Huang,4 Hao Liu,6 Yewei Zhang,7 Xiaolong Qi1 1Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China; 2Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital of Hebei Medical University, Xingtai, People’s Republic of China; 3Hepatic Surgery Center, Tongji Hospital, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 4Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China; 5Department of Hepatobiliary Surgery, Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of China; 6Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 7Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaolong Qi, Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People’s Republic of China, Email qixiaolong@vip.163.com Jitao Wang, Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital of Hebei Medical University, Xingtai, Hebei, People’s Republic of China, Email wangjt302@163.comObjective: To develop a nomogram for predicting post-hepatectomy liver failure (PHLF) in patients with resectable hepatocellular carcinoma (HCC) based on portal hypertension, the extent of resection, ALT, total bilirubin, and platelet count.Methods: Patients with HCC hospitalized from January 2015 to December 2020 were included in a retrospective cohort study. 595 HCC patients were divided into a training cohort (n=416) and a validation cohort (n=179) by random sampling. Univariate and multivariable analyses were performed to identify the independent variables to predict PHLF. The nomogram models for predicting the overall risk of PHLF and the risk of PHLF B+C were constructed based on the independent variables. Comparisons were made by using receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) with traditional models, such as FIB-4 score, APRI score, CP class (Child-Pugh), MELD score (model of end-stage liver disease), and ALBI score (albumin-bilirubin) to analyze the accuracy and superiority of the nomogram.Results: We discovered that portal hypertension (yes vs no) (OR=1.677,95% CI:1.817– 4.083, p=0.002), the extent of liver resection (OR=1.872,95% CI:3.937– 47.096, p=0.001), ALT (OR=1.003,95% CI:1.003– 1.016, P=0.003), total bilirubin (OR=1.036,95% CI:1.031– 1.184, p=0.005), and platelet count (OR= 1.004, 95% CI:0.982– 0.998, p=0.020) were independent risk factors for PHLF using multifactorial analysis. The nomogram models were constructed using well-fit calibration curves for each of these five covariates. When compared to the FIB4, ALBI, MELD, and CP score, our nomogram models have a better predictive value for predicting the overall risk of PHLF or the risk of PHLF B+C. The validation cohort’s results were consistent. DCA also confirmed the conclusion.Conclusion: Our models, in the form of static nomogram or web application, were developed to predict PHLF overall risk and PHLF B+C risk in patients with HCC, with a high prediction sensitivity and specificity performance than other commonly used scoring systems.Keywords: post-hepatectomy liver failure, hepatocellular carcinoma, nomogram, predictive modelhttps://www.dovepress.com/a-novel-nomogram-for-prediction-of-post-hepatectomy-liver-failure-in-p-peer-reviewed-fulltext-article-JHCpost-hepatectomy liver failurehepatocellular carcinomanomogrampredictive model
spellingShingle Wang J
Zhang Z
Shang D
Liao Y
Yu P
Li J
Chen S
Liu D
Miao H
Li S
Zhang B
Huang A
Liu H
Zhang Y
Qi X
A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
Journal of Hepatocellular Carcinoma
post-hepatectomy liver failure
hepatocellular carcinoma
nomogram
predictive model
title A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
title_full A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
title_fullStr A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
title_full_unstemmed A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
title_short A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
title_sort novel nomogram for prediction of post hepatectomy liver failure in patients with resectable hepatocellular carcinoma a multicenter study
topic post-hepatectomy liver failure
hepatocellular carcinoma
nomogram
predictive model
url https://www.dovepress.com/a-novel-nomogram-for-prediction-of-post-hepatectomy-liver-failure-in-p-peer-reviewed-fulltext-article-JHC
work_keys_str_mv AT wangj anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT zhangz anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT shangd anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT liaoy anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT yup anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT lij anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT chens anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT liud anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT miaoh anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT lis anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT zhangb anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT huanga anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT liuh anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT zhangy anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT qix anovelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT wangj novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT zhangz novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT shangd novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT liaoy novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT yup novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT lij novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT chens novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT liud novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT miaoh novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT lis novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT zhangb novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT huanga novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT liuh novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT zhangy novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy
AT qix novelnomogramforpredictionofposthepatectomyliverfailureinpatientswithresectablehepatocellularcarcinomaamulticenterstudy